Pune, India -- (SBWIRE) -- 05/12/2020 -- Infinium Global Research has recently published a global report on "Anticoagulant Reversal Drugs Market (Product Type - Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, Andexxa, and Other Product Types; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Others Distribution Channels): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025."

To Know More Request Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/18043

Rise in the Prevalence of Atrial Fibrillation and Cardiovascular Disease

Anticoagulant reversal drugs are required when there is a need to neutralize anticoagulant therapy in a situation, where there is a complication of bleeding such as in heart attack or stroke. Andexxa is the only drug launched by the Portola Pharmaceuticals Inc. that is used for reversing the effect of factor Xa inhibitors. It is used, when people are suffering from severe complications from blood clots.

Additionally, in 2019, Portola Pharmaceuticals Inc. has launched Andexxa with the name Ondexxya in Europe and there are fewer side effects of it. The objective of this launch is to manage the availability of Andexxa to as many hospitals and patients as possible to meet their higher requirements. This will help to increase the sale of the Andexxa in the hospital, which in turn boosts the anticoagulant reversal drugs.

The rise in the prevalence of atrial fibrillation and cardiovascular disease is the factor, which is likely to boost this market. As it is found that cardiovascular disease mainly found in the adult. For instance, about 40 % of the adult populations in the United States were diagnosed with a cardiovascular condition in 2018.

Growing Aging Population

Therefore, the growing aging population is anticipated to experience the rapid growth of the market. On the other hand, the approval of blockbuster drugs in recent years such as Andexxa and a strong pipeline are contributing to the growth of the market.

Government is Taking Initiatives Towards the Healthcare Expenditure

The increasing focus of the company in the R&D activities which, in turn, propels the market. The government is taking initiatives towards the healthcare expenditure, which helps to drive for the market. However, the availability of the high cost of the patent drugs yet remains one of the major restraints to this market. Moreover, many companies are taking initiative to launch the drug, which is used for reversing the effect of factor Xa inhibitors offer favorable opportunities in this market.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Anticoagulant Reversal Drugs Market is Included in the Report for Free."

North America is Expected to Hold the Maximum Market Share

Geographically, North America is the dominant region in this market and is expected to hold the maximum market share in the forecast period owing to increasing drug approval by the USFDA as well as involving in the prevention program of the blood disorder such as by Centers for Disease Control and Prevention. On another hand, Europe holds the second-largest market share in this market due to the recent launch of the Ondexxya and the continuous growth of the R&D activities by the companies.

Get this Section as a Free Customization in the Report Along With 30% Discount on the Study. https://www.infiniumglobalresearch.com/reports/customization/18043

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Anticoagulant Reversal Drugs Amidst COVID-19"

Anticoagulant Reversal Drugs Market Coverage

Chapter - 1  Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2  Executive Summary

=> Anticoagulant Reversal Drugs Market Highlights

=> Anticoagulant Reversal Drugs Market Projection

=> Anticoagulant Reversal Drugs Market Regional Highlights

Chapter - 3  Global Anticoagulant Reversal Drugs Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Anticoagulant Reversal Drugs Market

Chapter - 4  Anticoagulant Reversal Drugs Market Macro Indicator Analysis

Chapter - 5  Global Anticoagulant Reversal Drugs Market by Product Type

=> Prothrombin Complex Concentrates

=> Vitamin K

=> Protamine

=> Tranexamic Acid

=> Idarucizumab

=> Andexxa

=> Other Product Types

Chapter - 6  Global Anticoagulant Reversal Drugs Market by Distribution Channel

=> Hospital Pharmacies

=> Retail Pharmacies

=> Others Distribution Channels

Chapter - 7  Global Anticoagulant Reversal Drugs Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 8  Company Profiles and Competitive Landscape

=> Bausch Health Companies, Inc.

=> Pfizer, Inc.

=> Fresenius Kabi AG

=> Amneal Pharmaceuticals, Inc.

=> Boehringer Ingelheim GmbH

=> CSL Limited

=> Octapharma AG

=> Portola Pharmaceuticals, Inc.

=> Perosphere Pharmaceuticals, Inc.

Chapter - 9  Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-anticoagulant-reversal-drugs-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.